<div>The vaccine is under the human trial phase and once the effectiveness is proved, the pharma company will produce millions of doses in a couple of months. While the company will produce the first 100 million doses for the UK as per its deal signed with the nation, it will manufacture around 2 billion doses to be supplied worldwide by mid-2021.</div>